More than 50% of patients with severe asthma have high eosinophil levels, making them candidates for biologic therapies like Nucala and other drugs like ... IL-13 inhibitor Dupixent (dupilumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback